Internal Medicine, Gastroenterology · Flint, MI
NPI
1144292038
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
6240 Rashelle Dr, Suite 201
Flint, MI, 48507
Phone (810) 600-2888
Medicare paid, 2024
$118K
881 services
Medicare patients, 2024
612
Average age 74
Drug cost, 2024
$908K
1,152 prescriptions
Company payments, 2025
$1,374
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dilip M Desai was code 45385 (colonoscopy - lesion removal), 202 times for 201 patients. In total Dilip M Desai billed 881 services in 21 codes, and Medicare paid $118K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 202 | 201 | $215.23 | $43K |
| 43239 Upper GI Endoscopy | Facility | 140 | 139 | $98.55 | $14K |
| 43450 Digestive/Gastrointestinal | Facility | 91 | 86 | $31.82 | $2,895 |
| 99214 Office E&M - Established | Office | 79 | 64 | $97.23 | $7,681 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 75 | 75 | $186.25 | $14K |
| 43235 Upper GI Endoscopy | Facility | 70 | 65 | $96.06 | $6,724 |
| 45378 Lower GI Endoscopy - Other | Facility | 38 | 38 | $137.84 | $5,238 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 36 | 36 | $184.11 | $6,628 |
| 99213 Office E&M - Established | Office | 32 | 30 | $69.47 | $2,223 |
| 45380 Lower GI Endoscopy - Other | Facility | 28 | 28 | $110.78 | $3,102 |
| 43251 Upper GI Endoscopy | Facility | 18 | 18 | $160.31 | $2,886 |
| 43249 Upper GI Endoscopy | Facility | 16 | 12 | $125.96 | $2,015 |
| 99204 Office E&M - New | Office | 15 | 15 | $130.07 | $1,951 |
By year: 2022 $142K for 1,138 services; 2023 $141K for 1,092 services; 2024 $118K for 881 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dilip M Desai prescribed most often to Medicare patients was Omeprazole, with 231 prescriptions and refills. In total Dilip M Desai wrote 1,152 Medicare prescriptions that cost $908K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 231 | 604 | 104 | $3,150 |
| Mesalamine Generic | 134 | 325 | 32 | $178K |
| Dicyclomine Hcl Generic | 120 | 223 | 54 | $2,215 |
| Pantoprazole Sodium Generic | 83 | 213 | 38 | $1,561 |
| Ondansetron Hcl Generic | 46 | 51 | 35 | $235 |
| Famotidine Generic | 44 | 105 | 19 | $475 |
| Humira(Cf) Pen Adalimumab | 35 | 35 | Under 11 | $297K |
| Cholestyramine Cholestyramine (With Sugar) | 32 | 48 | Under 11 | $2,679 |
| Budesonide Dr Budesonide | 31 | 67 | 15 | $7,951 |
| Balsalazide Disodium Generic | 31 | 71 | Under 11 | $6,138 |
| Linzess Linaclotide | 27 | 49 | 14 | $23K |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 25 | 25 | 21 | $850 |
| Creon Lipase/Protease/Amylase | 21 | 33 | Under 11 | $40K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 20 | 20 | 19 | $544 |
| Ondansetron Odt Ondansetron | 18 | 20 | 15 | $491 |
Brand drugs: 174 claims; generic drugs: 978 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dilip M Desai $1,374 ($1,374 in general payments such as food, travel and fees) from 15 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $378.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 14 | $378 |
| Abbvie Inc. ABBV | 19 | $328 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $133 |
| Janssen Biotech, Inc. JNJ | 5 | $97.94 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $82.39 |
| Aimmune Therapeutics, Inc. | 3 | $62.36 |
| Gilead Sciences, Inc. GILD | 3 | $55.65 |
| Pfizer Inc. PFE | 3 | $51.44 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $39.96 |
| Intercept Pharmaceuticals, Inc. | 2 | $36.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.